InSite Vision | Zee News

Advertisement

NewsInSite Vision

InSite Vision News

Sun Pharmaceutical Industries

11 Apr 2016

Sun Pharma gets USFDA nod for eye inflammation drug

The company is likely to commercialise BromSite through its newly formed US-based division Sun Ophthalmics in the second half of 2016.

Sun Pharmaceutical Industries

29 Sep 2015

Sun Pharma makes tender offer to acquire InSite Vision

Drug major Sun Pharmaceutical Industries has made a tender offer to acquire US-based eyecare firm InSite Vision for USD 0.35 per share in cash.

16 Sep 2015

Sun Pharma up over 2% on deal with US-based InSite Vision

Sun Pharma's stock gained over 2 percent Wednesday as the company has entered into an agreement with InSite Vision to acquire the US-based eyecare firm for around USD 48 million plus related debt and other transaction costs to strengthen its branded ophthalmic portfolio in the American market.

Sun Pharmaceutical Industries

16 Sep 2015

Sun Pharma seals deal to acquire US-based InSite Vision

Drug major Sun Pharmaceutical Industries has entered into an agreement with InSite Vision to acquire the US-based eyecare firm for around USD 48 million plus related debt and other transaction costs to strengthen its branded ophthalmic portfolio in the US.

Loading...

NEWS ON ONE CLICK